ARTICLE | Clinical News
Tyrima: Phase II start
July 28, 2008 7:00 AM UTC
This quarter, CeNeRx will begin a double-blind, placebo-controlled, U.S. Phase II trial to evaluate oral Tyrima in over 270 patients. ...
Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
This quarter, CeNeRx will begin a double-blind, placebo-controlled, U.S. Phase II trial to evaluate oral Tyrima in over 270 patients. ...